JGP Global Gestao de Recursos »

Summit Therapeutics shares owned by JGP Global Gestao de Recursos

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by JGP Global Gestao de Recursos from 13F filings

Historical chart of JGP Global Gestao de Recursos investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by JGP Global Gestao de Recursos consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by JGP Global Gestao de Recursos

Quarter filed Position value Share count Share price at filing
2024-09-30 $374k 17k 21.90

More positions owned by JGP Global Gestao de Recursos

New Gold Common Stock (NGD)
Stoneco Ltd-a Common Stock (STNE)
Rhythm Pharmaceuticals Common Stock (RYTM)
Eli Lilly & Co Common Stock (LLY)
Beigene Ltd- Adr (BGNE)
Incyte Corp Common Stock (INCY)
Unitedhealth Group Common Stock (UNH)
Itau Unibanco Hldng-pref Adr (ITUB)
Intuitive Surgical Common Stock (ISRG)
Thermo Fisher Scientific Common Stock (TMO)
Danaher Corp Common Stock (DHR)
Stryker Corp Common Stock (SYK)
Merck & Co Common Stock (MRK)
Elevance Health Common Stock (ELV)
Regeneron Pharmaceuticals Common Stock (REGN)

View all positions for JGP Global Gestao de Recursos

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Jane Street
Susquehanna International
Citadel Advisors
Charles Schwab Investment Management
Standard Life Aberdeen
Darwin Global Management
Balyasny Asset Management
Northern Trust

View all funds holding Summit Therapeutics